| Literature DB >> 25809390 |
K Mori1, Y Yamagata1, S Aikou1, M Nishida1, T Kiyokawa1, K Yagi1, H Yamashita1, S Nomura1, Y Seto1.
Abstract
Transthoracic esophagectomy (TTE) is believed to have advantages for mediastinal lymphadenectomy in the treatment of resectable esophageal cancer despite its association with a greater incidence of pulmonary complications and postoperative mortality. Transhiatal esophagectomy is regarded as less invasive, though insufficient in terms of lymph node dissection. With the aim of achieving lymph dissection equivalent to that of TTE, we have developed a nontransthoracic esophagectomy (NTTE) procedure combining a video-assisted cervical approach for the upper mediastinum and a robot-assisted transhiatal approach for the middle and lower mediastinum. We prospectively studied 22 accumulated cases of NTTE and verified feasibility by analyzing perioperative and histopathological outcomes. We compared this group's short-term outcomes with outcomes of 139 equivalent esophageal cancer cases operated on at our institution by conventional TTE (TTE group). In the NTTE group, there were no procedure-related events and no midway conversions to the conventional surgery; the mean operation time was longer (median, 524 vs. 428 minutes); estimated blood loss did not differ significantly between the two groups (median, 385 mL vs. 490 mL); in the NTTE group, the postoperative hospital stay was shorter (median, 18 days vs. 24 days). No postoperative pneumonia occurred in the NTTE group. The frequencies of other major postoperative complications did not differ significantly, nor were there differences in the numbers of harvested mediastinal lymph nodes (median, 30 vs. 29) or in other histopathology findings. NTTE offers a new radical procedure for resection of esophageal cancer combining a cervical video-assisted approach and a transhiatal robotic approach. Although further accumulation of surgical cases is needed to corroborate these results, NTTE promises better prevention of pulmonary complications in the management of esophageal cancer.Entities:
Keywords: esophageal cancer; lymphadenectomy; minimally invasive esophagectomy; robot-assisted surgery; transhiatal esophagectomy
Mesh:
Year: 2015 PMID: 25809390 PMCID: PMC5132031 DOI: 10.1111/dote.12345
Source DB: PubMed Journal: Dis Esophagus ISSN: 1120-8694 Impact factor: 3.429
Figure 1(a) Lymph nodes (LNs) along the left recurrent laryngeal nerve (RLN) are being dissected en bloc with the esophagus (Eso), exposing the left main bronchus (LMB) and the aortic arch (AoArch). (b) An inverted V‐shaped cluster of LNs is dissected en bloc with the Eso from the LMB. The cluster includes the bilateral main bronchus LNs and subcarinal LNs and forms a V shape molded by the bronchi.
Figure 2Fields of lymphadenectomy by nontransthoracic esophagectomy. Black, gray, and white circles represent lymph nodes to be retrieved by the cervical, transhiatal robotic, and abdominal procedures, respectively. Nodes within the gray tone area were not considered to be mediastinal lymph nodes. This illustration is a modification of figures 1–4 in the Japanese Classification of Esophageal Cancer 10th Edition.
Clinicopathological characteristics
| NTTE ( | TTE ( |
| |
|---|---|---|---|
| Median age (range) | 64 (46–79) | 64 (39–80) | 0.652 |
| Gender (M/F) | 20/2 | 106/33 | 0.166 |
| Median BMI (range) | 21.4 (12.8–31.4) | 22.5 (18.4–26.7) | 0.146 |
| Histological type | |||
| SCC/AC/Other | 20/0/2 | 122/10/7 | 0.345 |
| Location, TN factors | |||
| Proximal/Middle/Distal/EGJ | 2/10/9/1 | 16/60/47/16 | 0.863 |
| cT (1/2/3) | 12/5/5 | 52/25/62 | 0.128 |
| cN (0/1) | 12/10 | 69/70 | 0.819 |
AC, adenocarcinoma; BMI, body mass index; cN, clinical nodal status; cT, clinical tumor depth; EGJ, esophagogastric junction; NTTE, nontransthoracic esophagectomy; SCC, squamous cell carcinoma; TN factors, American Joint Committee on Cancer Tumor Node Metastasis Classification, 7th Edition; TTE, transthoracic esophagectomy.
Short‐term outcomes
| NTTE ( | TTE ( |
| |
|---|---|---|---|
| Median (Range) | |||
| Operation | |||
| Duration of operation (minutes) | 524 (445–724) | 428 (250–786) | <0.0001 |
| Blood loss (mL) | 385 (30–890) | 490 (20–2830) | 0.117 |
| Postoperative course | |||
| Hospital stay (days) | 18 (11–41) | 24 (13–204) | 0.0013 |
*Wilcoxon rank sum test, **Fisher's exact test. NTTE, nontransthoracic esophagectomy; RLN, recurrent laryngeal nerve; TTE, transthoracic esophagectomy.
Pathology findings
| NTTE ( | TTE ( |
| ||
|---|---|---|---|---|
| TNM | ||||
| T category | 1/2/3/4 | 16/2/4/0 | 70/12/53/4 | 0.22 |
| N category | 0/1 | 12/10 | 67/72 | 0.650 |
| Nodal metastasis | ||||
| Upper mediastinum | Yes/No | 4/18 | 40/99 | 0.441 |
| Middle mediastinum | Yes/No | 1/21 | 21/118 | 0.314 |
| Lower mediastinum | Yes/No | 1/21 | 11/128 | 1.000 |
| R category | 0/1 | 21/1 | 134/5 | 0.592 |
*Fisher's exact test. N, node; NTTE, nontransthoracic esophagectomy; R, resection; T, tumor; TTE, transthoracic esophagectomy.
Figure 3Box‐and‐whisker plot of the lymph node yield (numbers) by the two approaches. The distributions of the lymph node yield by the two approaches were quite similar to each other in the three loci of the mediastinum.